4//SEC Filing
NephroGenex, Inc. 4
Accession 0001559058-15-000005
CIK 0001338095operating
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 11:54 AM ET
Size
4.8 KB
Accession
0001559058-15-000005
Insider Transaction Report
Form 4
Hamill John
Chief Financial Officer
Transactions
- Award
Common Stock
2015-11-10+136,381→ 136,381 total
Footnotes (1)
- [F1]All shares of common stock are represented by unvested restricted stock units. The restricted stock units will vest in equal quarterly installments over a three year period beginning January 1, 2016.
Documents
Issuer
NephroGenex, Inc.
CIK 0001338095
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001338095
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 11:54 AM ET
- Size
- 4.8 KB